Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study

Lipid metabolism derangement contributes to increased cardiovascular risk in Rheumatoid Arthritis (RA). It is still debated whether and how tocilizumab, an interleukin-6 receptor inhibitor used in active RA, impacts cardiovascular risk. We studied the effect of tocilizumab on the regulation of macro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Greco, Daniela, Gualtierotti, Roberta, Agosti, Pasquale, Adorni, Maria Pia, Ingegnoli, Francesca, Rota, Matteo, Bernini, Franco, Meroni, Pier Luigi, Ronda, Nicoletta
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7408911/
https://ncbi.nlm.nih.gov/pubmed/32650513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072157
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars